Organisation paid for research Program year 2025 Source: CMS Open Payments

Keith A Marcus MD Inc

Neither a doctor nor a teaching hospital

Research payments

$762,470

34 payments

Through program year 2025, Keith A Marcus MD Inc is reported as receiving $762,470 in research payments, across 34 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$657,569	29
2024	Research	$18,062	2
2023	Research	$86,839	3

Breakdown

Who paid Research payments · program years 2023–2025

AbbVie, Inc. $678,133 25 payments
Galderma Laboratories, L.P. $84,337 9 payments

Studies the money was for Research payments · program years 2023–2025

A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL) $472,924 7 payments
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naive Adult Participants With Glabellar Lines $86,839 3 payments
A randomized, evaluator-blinded, parallel group, comparator-controlled, multicenter study to evaluate the safety and effectiveness and safety of GP0112 for cheek augmentation, midface volumization and correction of midface contour deficiencies $84,337 9 payments
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) $82,404 12 payments
M24-704 - A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) $32,627 1 payment
A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL) $1,775 1 payment
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) $1,564 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.